Joel Isaacson & Co., LLC View Ray, Inc. Transaction History

Joel Isaacson & Co., LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$3.65 - $4.82 $76,650 - $101,220	21,000 Added 21.0%	121,000 $0
Q2 2022 Jul 15, 2022	SELL	$2.42 - $4.05 $251,680 - $421,200	-104,000 Reduced 50.98%	100,000 $265,000
Q1 2022 Apr 21, 2022	SELL	$3.45 - $5.83 $34,500 - $58,300	-10,000 Reduced 4.67%	204,000 $685,000
Q4 2021 Jan 19, 2022	BUY	$4.89 - $7.59 $48,900 - $75,900	10,000 Added 4.9%	214,000 $1.18 Million
Q3 2021 Oct 21, 2021	BUY	$5.18 - $7.41 $155,400 - $222,300	30,000 Added 17.24%	204,000 $1.47 Million
Q2 2021 Jul 20, 2021	BUY	$3.94 - $6.75 $122,140 - $209,250	31,000 Added 21.68%	174,000 $1.15 Million
Q1 2021 Apr 23, 2021	BUY	$4.03 - $7.25 $72,540 - $130,500	18,000 Added 14.4%	143,000 $622,000
Q4 2020 Jan 22, 2021	BUY	$2.78 - $4.5 $209,889 - $339,750	75,500 Added 152.53%	125,000 $478,000
Q2 2020 Jul 21, 2020	SELL	$1.66 - $2.73 $830 - $1,365	-500 Reduced 1.0%	49,500 $111,000
Q1 2020 Apr 21, 2020	SELL	$1.35 - $4.05 $81,000 - $243,000	-60,000 Reduced 54.55%	50,000 $125,000
Q4 2019 Jan 24, 2020	BUY	$2.3 - $4.6 $252,999 - $505,999	110,000 New	110,000 $464,000

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Joel Isaacson & Co., LLC with notifications on news.